Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN13837 in Acute Spinal Cord Injury
NCT01502631Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial in spinal cord injury (SCI) comparing SUN13837 with Placebo (2 arms). Primary endpoint: Total Spinal Cord Independence Measure Version III at 16 weeks. Started Aug 2012; status: completed.
02
Drugs
sun13837
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT01502631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502631.